Monoclonal Antibody to Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1)
NB; DAN; NO3; DAND1; Differential Screening-Selected Gene Aberrant In Neuroblastoma; DAN domain family member 1
- Product No.MAP853Hu21
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- SourceMonoclonal antibody preparation
- HostMouse
- Potency (Clone Number)n/a
- Ig Isotype IgG
- PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
- LabelNone
- Immunogen n/a
- Buffer FormulationPBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
- TraitsLiquid
- Concentration1mg/mL
- Organism Species Moren/a
- ApplicationsWB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies. - Download n/a
- UOM 20µl100µl 200µl 1ml 10ml
-
FOB
US$ 122
For more details, please contact local distributors!US$ 284
For more details, please contact local distributors! US$ 406
For more details, please contact local distributors! US$ 1015
For more details, please contact local distributors! US$ 4060
For more details, please contact local distributors!
-
Packages (Simulation)
-
Packages (Simulation)
-
ISO9001: 2008, ISO13485: 2003 Registered
SPECIFITY of the Monoclonal Antibody to Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1)
The antibody is a mouse monoclonal antibody raised against NBL1. It has been selected for its ability to recognize NBL1 in immunohistochemical staining and western blotting.
USAGE of the Monoclonal Antibody to Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1)
Western blotting: 0.2-2µg/mL;1:500-5000
Immunohistochemistry: 5-20µg/mL;1:50-200
Immunocytochemistry: 5-20µg/mL;1:50-200
Optimal working dilutions must be determined by end user.
STORAGE of the of the Monoclonal Antibody to Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1)
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY of the Monoclonal Antibody to Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1)
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
GIVEAWAYS
INCREMENT SERVICES
Antibody Labeling Customized Service
Protein A/G Purification Column
Staining Solution for Cells and Tissue
Positive Control for Antibody
Tissue/Sections Customized Service
Phosphorylated Antibody Customized Service
Western Blot (WB) Experiment Service
Immunohistochemistry (IHC) Experiment Service
Immunocytochemistry (ICC) Experiment Service
Flow Cytometry (FCM) Experiment Service
Immunoprecipitation (IP) Experiment Service
Immunofluorescence (IF) Experiment Service
Buffer
DAB Chromogen Kit
SABC Kit
Long-arm Biotin Labeling Kit
Real Time PCR Experimental Service
Related products
| Catalog No. | Organism species: Homo sapiens (Human) | Applications (RESEARCH USE ONLY!) |
| RPP853Hu01 | Recombinant Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAP853Hu01 | Polyclonal Antibody to Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) | WB; IHC; ICC; IP. |
| MAP853Hu21 | Monoclonal Antibody to Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) | WB; IHC; ICC; IP. |
| SEP853Hu | ELISA Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCP853Hu | CLIA Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) | Chemiluminescent immunoassay for Antigen Detection. |
| LMP853Hu | Multiplex Assay Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |
| CGP853Hu01 | cDNA of Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) | PCR; Protein Expression; etc. |